Health Care & Life Sciences » Biotechnology | Green Cross Holdings Corp.

Green Cross Holdings Corp. | Mutual Funds

Mutual Funds that own Green Cross Holdings Corp.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Government Pension Fund - Global (The)
574,957
1.22%
-179,444
0%
12/31/2017
Vanguard Total International Stock Index Fund
372,062
0.79%
0
0%
07/31/2018
iShares Core MSCI Emerging Markets ETF
257,334
0.55%
0
0.01%
09/05/2018
Invesco Funds Series 5 - Korean Equity Fund
190,000
0.4%
-20,000
5.79%
03/29/2018
Vanguard Developed Markets Index Fund
150,726
0.32%
0
0%
07/31/2018
DFA Emerging Markets Core Equity Portfolio
105,383
0.22%
0
0.01%
04/30/2018
Mirae Asset TIGER 200
98,750
0.21%
5,905
0.1%
01/31/2018
DFA Emerging Markets Small Cap Series
76,308
0.16%
-11,955
0.03%
01/31/2018
Vanguard FTSE All World (ex-US) Small Cap
73,449
0.16%
5,196
0.03%
07/31/2018
Mirae Asset TIGER Health Care ETF
50,101
0.11%
11,873
0.93%
04/30/2018

About Green Cross Holdings

View Profile
Address
107 Ihyeon-ro 30beon-gil
Yongin GY 16924
Korea, Republic Of
Employees -
Website http://www.greencross.com
Updated 07/08/2019
Green Cross Holdings Corp. is a holding company of Green Cross Corp. that engages in the manufacture of pharmaceutical products. It establishes and coordinates business strategies for Green Cross subsidiaries that launch business and investment portfolio management. Its products include prescription drugs such as blood derivatives, cerebrovascular disease treatment, fibrinolytic agent, vaccines, hunter syndrome drug, herbal medicine, and recombinant.